The Mastodon migration from Twitter in 2022 was massive for the non-commercial community network: The number of accounts swelled with more than…
-
Science Communication A Mastodon Migration From Bluesky Would Be DifferentRead more
-
Science Communication How Is Science Twitter’s “Mastodon Migration” Panning Out?Read more
“Thousands of scientists are cutting back on Twitter, seeding angst and uncertainty.” And Mastodon was the most common destination if they opened…
-
Science Communication Mastodon’s Growth, and Communities BranchingRead more
It’s coming up to 6 months since Musk took over Twitter, sending many of us over to Mastodon. “Scalloped growth” is what…
-
Science Communication Some Shortcuts to Giving Mastodon a TryRead more
We’ve been conditioned by a super-slick glide path to getting hooked into commercial social media. So facing the comparative complexity of Mastodon…
-
Science Communication Mastodon Growth Numbers Might Not Mean What You Think They MeanRead more
Mastodon’s growth in the last month has been extraordinarily fast – but just how fast? Did the number of users jump up…
-
Science Communication Reflecting on Twitter, White Flight, & “Quote Tweet” Tensions at MastodonRead more
Why can’t we “quote boost” at Mastodon, the way we can “quote tweet” at Twitter? That might sound like an innocuous question…
-
Science Communication Mapping the Mastodon Migration: Is It a One-Way Trip or an Each-Way Bet for Science Twitter?Read more
Like many people, I opened a Mastodon account on the weekend the Musk era began on Twitter. This post picks up from…
-
Covid-19 A Bumper Month of Clinical Trial News (NextGen Covid Vax Update)Read more
It was a big month for clinical trials of next generation Covid vaccines. An exciting phase 1/2 trial in Africa for an…
-
Evidence Beyond Belief: How Evidence Shows What Really Works (Book Review)Read more
There are several reasons to buy Helen Pearson’s excellent new book, Beyond Belief: How Evidence Shows What Really Works—whether you want to…
-
Covid-19 Another Intranasal Covid Vaccine Trial Starting in the US (NextGen Vax Monthly Update)Read more
This month intranasal and inhaled versions of a Covid vaccine are heading into a phase 1 trial in the US. The vaccine…
-
Bias There’s Still Too Much Uncertainty About Conflict of Interest BiasRead more
A paper published this month got me frustrated, yet again, about this situation: There really is still too much uncertainty about conflict…
-
Covid-19 Accelerating Development for Some NextGen Covid Vaxes (Update No 39)Read more
Several next generation Covid vaccines are now advancing into mid- or late-stage trials. So this month, I have started a new section—a…